Indianapolis, IN, United States of America

Donald Paul Matthews

This inventor holds 51 USPTO granted patents, plus 9 CIPO patents and 3 EPO patents, primarily in Androgen Receptor Modulators (CPC class 536 ). Top assignees: Merrell Dow Pharmaceuticals, Eli Lilly and Company, Merrell Pharmaceuticals, Inc.. Active years: 1978-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Paul Matthews. Retrieved from https://idiyas.com/inventor/donald-paul-matthews

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 88.2

 

 

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 226(Granted Patents)

Forward Citations (Not Self Cited) = 213(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Midland, MI (US) (1978)
  • West Chester, OH (US) (1989 - 1998)
  • Indianapolis, IN (US) (1980 - 2014)

Company Filing History:


Years Active: 1978-2014

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Androgen Receptor Modulators
PPAR Modulators
Steroid Hormone Modulators
Ribonucleotide Reductase Inhibitors
Thione Inhibitors
Adrenergic Agonists
Pharmaceutically Active Compounds
Triaryl-Ethylene Derivatives
Carcinoma Treatment
Hypoglycemic Agents
Bi-1H-Imidazoles
Amines
51 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Donald Paul Matthews' Ongoing Quest for Technological Advancements

Introduction:

Donald Paul Matthews, based in Indianapolis, IN (US), is a prolific inventor known for his unwavering commitment to pushing the boundaries of innovation. With a remarkable track record of 51 patents, Matthews continues to make significant contributions to society through his groundbreaking technologies.

Latest Patents:

Matthews' latest patents showcase his expertise in creating impactful solutions. One notable invention is the "4-aminobenzonitrile selective androgen receptor modulators," which introduces novel selective androgen receptor modulators and pharmaceutical compositions with promising therapeutic potential. Another patent, "Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators," addresses physiological disorders such as reduced bone mass and muscle strength, demonstrating his focus on improving healthcare outcomes.

Career Highlights:

Having worked at renowned companies like Merrell Dow Pharmaceuticals and Eli Lilly and Company, Matthews has honed his skills and knowledge in the field of pharmaceuticals and healthcare. His diverse experience has allowed him to innovate across various domains, contributing to his impressive portfolio of patents.

Collaborations:

Throughout his career, Matthews has collaborated with industry peers such as James R McCarthy and Anthony John Shuker. These partnerships have not only enriched his professional journey but have also led to the development of groundbreaking technologies that benefit society as a whole.

Conclusion:

In conclusion, Donald Paul Matthews stands as a true pioneer in the world of inventions, driven by his passion for creating technologies that have a positive impact on society. With a strong focus on innovation and excellence, Matthews continues to inspire the next generation of inventors and innovators to strive for greatness in their pursuits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…